Ophthalmology Times51m
Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema
UBX1325 is a novel BCL-xL inhibitor designed to eliminate senescent cells in diabetic retinal blood vessels, while leaving ...
Behind the mask: We’ve compiled ten face masks for perfect skin
We've gathered ten face masks for perfect skin, from moisturizing and refreshing to treating imperfections and luxury masks ...
The Manila Times10m
Antibody-based therapy discovered at The Lundquist Institute is several steps closer to treating a lethal fungal infection
Ashraf Ibrahim, PhD, an investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center for ...
We have to stop belittling endometriosis: it’s so much more than a ‘bad period’
Endometriosis is a whole body disease – and it’s time doctors, employers and, well, everyone, better understood that ...